Novavax · 3 days ago
Director, Intellectual Property & Transactions
United States
Full-time
Remote
Director/Executive
$226K/yr - $305K/yr
10+ years expNovavax is a mission-driven company focused on eradicating disease and saving lives. They are seeking a Director of Intellectual Property & Transactions who will manage outside counsel, develop IP strategies, and support licensing and due diligence activities.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Coordinate with research & development to identify new inventions; implement strategies for patent protection throughout all phases of development
Direct outside counsel on preparation and prosecution of worldwide patent portfolio; assist with patentability assessments
Develop a thorough understanding of Novavax’ current and planned business activities, products, competitors, and markets, and keep abreast of developing IP and other legal trends, laws and regulations
Lead freedom-to-operate initiative and support mitigation measures
Identify training needs within the company and develop training materials on relevant IP laws and related business issues
Other matters and duties as may be assigned
Qualification
Required
Bachelor's degree in a life science discipline with emphasis in organic chemistry and/or immunology
Juris Doctorate degree
Registration as a patent attorney with USPTO and member of a state bar
10-12 years of relevant experience in patent prosecution with global portfolios
Strong core patent prosecution skills and ability to independently manage IP dockets and drive strategy with outside counsel
Demonstrated ability to collaborate, build, and sustain effective partnerships with key stakeholders and project teams
Ability to travel internationally up to 25%
Preferred
A combination of law firm and in-house experience
Advanced degree
Benefits
Annual bonus
Equity grants
Professional career development/growth opportunities
Comprehensive benefits package including medical, dental, vision, Rx, STD, LTD, Life, Optional Life, 401(k) plan
Company
Novavax
Novavax is a biotechnology company that focuses on the discovery and development of innovative vaccines for various infectious diseases.
501-1000 employees
H1B Sponsorship
Novavax has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (16)
2023 (17)
2022 (19)
2021 (24)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.94BKey Investors
SK BioscienceGovernment of United States of AmericaRA Capital Management
2025-08-21Post Ipo Debt· $225M
2023-08-08Post Ipo Equity· $85M
2022-12-15Post Ipo Equity· $74.75M
Leadership Team
John Jacobs
President, CEO and Member of the Board of Directors
Ruxandra Draghia Akli
Executive Vice President, Head of Research and Development
Recent News
bloomberglaw.com
2026-01-03
The Motley Fool
2025-12-11
2025-12-03
Company data provided by crunchbase